1Hoelzel W,Weykamp C,Jeppsson JO,et al.IFCC reference system for measurement of hemoglobin A1cin human blood and the national standardization schemes in the United States,Japan,and Sweden:a method-comparison study[J].Clin Chem,2004,50(1):166-174.
4No authors listed.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.The Diabetes Control and Complications Trial Research Group[J].N Engl J Med,1993,329(14):977-986.
5Turner RC,Holman RR,Cull CA,et al.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33)[J].Lancet,1998,352(9131):837-853.
6Stratton IM,Adler AI,Neil HA,et al.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes(UKPDS 35):prospective observational study[J].BMJ,2000,321(7258):405-412.
7Gillett MJ.International Expert Committee Report on the Role of the A1cAssay in the Diagnosis of Diabetes:Diabetes Care 2009;32(7):1327-1334[J].Clin Biochem Rev,2009,30(4):197.
8American Diabetes Association.Standards of medical care in diabetes 2010[J].Diabetes Care,2010,33(S1):S11-S61.
9Herman WH,Dungan KM,Wolffenbuttle BH,et al.Racial and ethnic differences in mean plasma glucose,hemoglobin A1c,and 1'5-anhydroglucitol in over 2000 patients with type 2 diabetes[J].Clin Endocrinol Matab,2009,94(5):1689-1694.
10Bao Y,Ma X,Li H,et al.Glycated haemoglobin A1cfor diagnosing diabetes in Chinese population:cross sectional epidemiological survey[J].BMJ,2010,340:c2249.
